Get 20% Free Customization In This Report

Buy this report from - $3456

Custom Assays Market by Type (Activity Assays, Competitive Assays, ELISA Assays, Sandwich Assays, and Screening Assays), Technology (Flow Cytometry, Membrane Based/Planar Assays, and Suspension/ Bead Based Assays), and End User (Academic & Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations, and Food & Beverage Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Diagnostics and Biotech	LI_184097	Pages: NA	Jun 2018 \| 352 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.

The global custom assays market is driven by several factors such as increasing R&D activities in the life science and biotechnology industry, growing number of academic research institutes, and increasing demand for tissue diagnostic & cell based diagnostics to treat clinical conditions such as cancer, HIV, and other infectious diseases. However, challenges in optimization and standardization of an assay will restrain the market growth. Emerging biochip technology will provide opportunities for the market growth.

The report segments the global custom assays market based on type, technology, end user, and region. Based on type, it is segmented into activity assays, competitive assays, ELISA assays, sandwich assays, screening assays, and other assays. Based on technology it is segmented into flow cytometry, membrane based/planar assays, suspension/ bead based assays, and others. Based on end user, it is divided into academic & research institutes, life science industries, biotechnology companies, diagnostic centers, contract research organizations, and food & beverage companies. Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players that operate in the market include Promega Corporation, Bioassay Systems, Merck & Co., Inc., Thermo Fisher Scientific Inc., R & D Systems Inc. (Biotechne Inc.), Fluidigm, Luminex Corporation, F. Hoffmann-La Roche AG, QIAGEN N.V, Quansys Bioscience, and BD Biosciences.

Key Benefits

The study provides an in-depth analysis of the global market with current trends and future estimations to elucidate imminent investment pockets.
The report provides a quantitative analysis from 2016 to 2023, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions has been provided that helps in determining prevailing opportunities in these regions.
Key market players within the market are profiled in the report and their strategies thoroughly analyzed, which helps in understanding the competitive outlook of the global market.
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Custom Assays Market Key Segments:

By Type

Activity Assays
Competitive Assays
ELISA Assays
Sandwich Assays
Screening Assays
Others

By Technology

Flow Cytometry
Membrane Based/Planar Assays
Suspension/ Bead Based Assays
Others

By End User

Academic & Research Institutes
Life Science Industries
Biotechnology Companies
Diagnostic Centers
Contract Research Organizations
Food & Beverage Companies

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 CUSTOM ASSAYS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ACTIVITY ASSAYS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. COMPETITIVE ASSAYS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. ELISA ASSAYS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SANDWICH ASSAYS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. SCREENING ASSAYS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHER ASSAYS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 CUSTOM ASSAYS MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. FLOW CTOMETRY

5.2.1. Market size and forecast

5.3. MEMBRANE BASED/PLANAR ASSAYS

5.3.1. Market size and forecast

5.4. SUSPENSION/BEAD BASED ASSAYS

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

Chapter: 6 CUSTOM ASSAYS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. ACADEMIC & RESEARCH INSTITUTES

6.2.1. Market size and forecast

6.3. LIFE SCIENCE INDUSTRIES

6.3.1. Market size and forecast

6.4. BIOTECHNOLOGY COMPANIES

6.4.1. Market size and forecast

6.5. DIAGNOSTIC CENTRES

6.5.1. Market size and forecast

6.6. CONTRACT RESEARCH ORGANIZATIONS

6.6.1. Market size and forecast

6.7. FOOD & BEVERAGE COMPANIES

6.7.1. Market size and forecast

Chapter: 7 CUSTOM ASSAYS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America custom assays market by type
7.2.5. North America custom assays market by technology
7.2.6. North America custom assays market by end user

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe custom assays market by type
7.3.5. Europe custom assays market by technology
7.3.6. Europe custom assays market by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific custom assays market by type
7.4.5. Asia-Pacific custom assays market by technology
7.4.6. Asia-Pacific custom assays market by end user

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

7.5.4. LAMEA custom assays market by type
7.5.5. LAMEA custom assays market by technology
7.5.6. LAMEA custom assays market by end user

Chapter: 8 COMPANY PROFILES

8.1. PROMEGA CORPORATION

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. BIOASSAY SYSTEMS

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. MERCK & CO., INC.

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. THERMO FISHER SCIENTIFIC INCORPORATION

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. R & D SYSTEMS INC.

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. FLUIDIGM

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. LUMINEX CORPORATION

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. F. HOFFMANN-LA ROCHE AG

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. QIAGEN N.V.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. QUANSYS BIOSCIENCE

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

8.11. BD BIOSCIENCES

8.11.1. Operating business segments
8.11.2. Business performance
8.11.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.